BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34445620)

  • 21. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
    Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
    ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymer "ruthenium-cyclopentadienyl" conjugates - New emerging anti-cancer drugs.
    Moreira T; Francisco R; Comsa E; Duban-Deweer S; Labas V; Teixeira-Gomes AP; Combes-Soia L; Marques F; Matos A; Favrelle A; Rousseau C; Zinck P; Falson P; Garcia MH; Preto A; Valente A
    Eur J Med Chem; 2019 Apr; 168():373-384. PubMed ID: 30826512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid.
    Graminha AE; Honorato J; Dulcey LL; Godoy LR; Barbosa MF; Cominetti MR; Menezes AC; Batista AA
    J Inorg Biochem; 2020 May; 206():111021. PubMed ID: 32163810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes.
    Gałczyńska K; Drulis-Kawa Z; Arabski M
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors.
    de Camargo MS; De Grandis RA; da Silva MM; da Silva PB; Santoni MM; Eismann CE; Menegário AA; Cominetti MR; Zanelli CF; Pavan FR; Batista AA
    Biometals; 2019 Feb; 32(1):89-100. PubMed ID: 30506342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
    Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
    Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
    Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
    J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
    Notaro A; Gasser G
    Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
    Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
    Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ruthenium(II)-Arene Thiocarboxylates: Identification of a Stable Dimer Selectively Cytotoxic to Invasive Breast Cancer Cells.
    Stephens LJ; Levina A; Trinh I; Blair VL; Werrett MV; Lay PA; Andrews PC
    Chembiochem; 2020 Apr; 21(8):1188-1200. PubMed ID: 31701616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of
    Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
    Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands.
    Sun J; Chen WX; Song XD; He SF; Chen JX; Mei J; Zhu XX; Wu T
    Anticancer Agents Med Chem; 2018; 18(1):110-120. PubMed ID: 28425859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic and anticancer properties of new ruthenium polypyridyl complexes with different lipophilicities.
    Florence Tikum A; Jeon YJ; Lee JH; Park MH; Bae IY; Kim SH; Lee HJ; Kim J
    J Inorg Biochem; 2018 Mar; 180():204-210. PubMed ID: 29329027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lead to hit ruthenium-cyclopentadienyl anticancer compounds: Cytotoxicity against breast cancer cells, metabolic stability and metabolite profiling.
    Maximiano I; Henriques C; Teixeira RG; Marques F; Valente A; Antunes AMM
    J Inorg Biochem; 2024 Feb; 251():112436. PubMed ID: 38016328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, DNA Cleavage Activity, Cytotoxicity, Acetylcholinesterase Inhibition, and Acute Murine Toxicity of Redox-Active Ruthenium(II) Polypyridyl Complexes.
    Alatrash N; Narh ES; Yadav A; Kim MJ; Janaratne T; Gabriel J; MacDonnell FM
    ChemMedChem; 2017 Jul; 12(13):1055-1069. PubMed ID: 28605571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polypyridyl Ruthenium(II) complex-induced mitochondrial membrane potential dissipation activates DNA damage-mediated apoptosis to inhibit liver cancer.
    Li Y; Wu Q; Yu G; Li L; Zhao X; Huang X; Mei W
    Eur J Med Chem; 2019 Feb; 164():282-291. PubMed ID: 30599417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
    Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
    J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.